Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.

about

Role of epigenetics-microRNA axis in drug resistance of multiple myeloma.Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy The Roles of ROS in Cancer Heterogeneity and Therapy.

P2860

Q39379624-E0D85190-5132-42C3-846F-47AF7776B362 Q39433158-0BCA2E41-C2E5-4BF0-A9EF-3A392586D374 Q46020509-3E1CE677-9986-443C-BEA1-69ABE4119FC2

P2860

Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.

Item

http://www.wikidata.org/entity/Q39137683

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.

@en

Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.

@nl

type

Item

label

Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.

@en

Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.

@nl

prefLabel

Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.

@en

Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.

@nl

P1476

Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.

@en

P2093

Chandra Sekhar Chirumamilla

http://www.w3.org/2001/XMLSchema#string

Claudina Perez-Novo

http://www.w3.org/2001/XMLSchema#string

Farnaz Sedigheh Takhsha

http://www.w3.org/2001/XMLSchema#string

Muriel Cuendet

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development

DNA methylation patterns and epigenetic memory

WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

Thalidomide is an inhibitor of angiogenesis

Covalent histone modifications--miswritten, misinterpreted and mis-erased in human cancers

MicroRNAs: target recognition and regulatory functions

Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development

Initial genome sequencing and analysis of multiple myeloma

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study

P2888

s13148-017-0319-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1186/S13148-017-0319-5

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wim Vanden Berghe

Mark Issa

P5008

ScienceSource

P577

2017-02-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083754002

http://www.w3.org/2001/XMLSchema#string

P698

28203307

http://www.w3.org/2001/XMLSchema#string

P921

multiple myeloma

multiple drug resistance

P932

5303245

http://www.w3.org/2001/XMLSchema#string

Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.

about

P2860

P2860

Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P478

P50

P5008

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P275

P2860

P2888

P304

P31

P356

P478

P50

P5008

P577

P6179

P698

P921

P932